Drug intelligence / Profile preview

Lactobacillus paracasei IOB413

Development stage: Preclinical
Lead developer: Tianjin InnoOrigin Biological Biotechnology
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Lactobacillus paracasei IOB413 (also known as Lacticaseibacillus paracasei IOB413) is a probiotic strain developed by Tianjin InnoOrigin Biological Biotechnology. [2] Isolated from naturally fermented sourdough, it is formulated as a postbiotic powder. This biologic product is designed to promote gut health by targeting and inhibiting pathogenic bacteria, specifically *Helicobacter pylori* and *Salmonella enteritidis*, and by regulating the balance of the intestinal microbiota. Additionally, research has explored its potential to influence cognitive function in Alzheimer's disease models through the gut-brain axis.

Other names: Lacticaseibacillus paracasei IOB413

Beyond the preview

Go deeper on Lactobacillus paracasei IOB413.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactobacillus paracasei IOB413.

Explore the full profile